Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial

Atsushi Kawahara,1–3 Tsugiaki Utsunomiya,4 Yuji Kato,2 Yoshinori Takayanagi3 1Department of Ophthalmology, Sapporo Tokushukai Hospital, Sapporo, Hokkaido, Japan; 2Sapporo Kato Eye Clinic, Sapporo, Hokkaido, Japan; 3Takayanagi Clinic, Kushiro, Hokkaido, Japan; 4Department of Ophthalmology,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kawahara A, Utsunomiya T, Kato Y, Takayanagi Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/8f45375696624ce8ba137a571e893953
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8f45375696624ce8ba137a571e893953
record_format dspace
spelling oai:doaj.org-article:8f45375696624ce8ba137a571e8939532021-12-02T01:06:47ZComparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial1177-5483https://doaj.org/article/8f45375696624ce8ba137a571e8939532016-03-01T00:00:00Zhttps://www.dovepress.com/comparison-of-effect-of-nepafenac-and-diclofenac-ophthalmic-solutions--peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Atsushi Kawahara,1–3 Tsugiaki Utsunomiya,4 Yuji Kato,2 Yoshinori Takayanagi3 1Department of Ophthalmology, Sapporo Tokushukai Hospital, Sapporo, Hokkaido, Japan; 2Sapporo Kato Eye Clinic, Sapporo, Hokkaido, Japan; 3Takayanagi Clinic, Kushiro, Hokkaido, Japan; 4Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan Background: The aim of this study was to compare the effects of nepafenac ophthalmic suspension 0.1% (Nevanac) and diclofenac sodium ophthalmic solution 0.1% (Diclod) on the cornea, tear film, and ocular surface after cataract surgery. Methods: A total of 60 eyes (60 patients) were selected for this study, with no ocular diseases other than cataract (scheduled for cataract surgery by one surgeon). Patients were randomly enrolled to receive nepafenac or diclofenac in the perioperative period, and cataract surgery was performed using torsional microcoaxial phacoemulsification and aspiration with intraocular lens implantation via a transconjunctival single-plane sclerocorneal incision at the 12 o’clock position. We compared intra- and intergroup differences preoperatively and postoperatively in conjunctival and corneal fluorescein staining scores, tear film breakup times, Schirmer’s tests, the Dry Eye Related Quality of Life Scores, and tear meniscus areas using anterior segment optical coherence tomography. Results: The diclofenac group had significantly higher conjunctival and corneal fluorescein staining scores at 4 weeks postoperatively compared with the nepafenac group (P<0.001). Within the diclofenac group, significantly higher conjunctival and corneal fluorescein staining scores were noted at 4 weeks postoperatively than those seen preoperatively (P<0.001) and at 1 week postoperatively (P<0.001). No statistically significant differences were found in any other items. Conclusions: Nepafenac ophthalmic suspension 0.1% is considered safe for the corneal epithelium after cataract surgery. Keywords: nepafenac, diclofenac, cornea, tear film, ocular surface, cataract surgeryKawahara AUtsunomiya TKato YTakayanagi YDove Medical Pressarticlenepafenacdiclofenaccorneatear filmocular surfacecataract surgeryOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2016, Iss Issue 1, Pp 385-391 (2016)
institution DOAJ
collection DOAJ
language EN
topic nepafenac
diclofenac
cornea
tear film
ocular surface
cataract surgery
Ophthalmology
RE1-994
spellingShingle nepafenac
diclofenac
cornea
tear film
ocular surface
cataract surgery
Ophthalmology
RE1-994
Kawahara A
Utsunomiya T
Kato Y
Takayanagi Y
Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial
description Atsushi Kawahara,1–3 Tsugiaki Utsunomiya,4 Yuji Kato,2 Yoshinori Takayanagi3 1Department of Ophthalmology, Sapporo Tokushukai Hospital, Sapporo, Hokkaido, Japan; 2Sapporo Kato Eye Clinic, Sapporo, Hokkaido, Japan; 3Takayanagi Clinic, Kushiro, Hokkaido, Japan; 4Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan Background: The aim of this study was to compare the effects of nepafenac ophthalmic suspension 0.1% (Nevanac) and diclofenac sodium ophthalmic solution 0.1% (Diclod) on the cornea, tear film, and ocular surface after cataract surgery. Methods: A total of 60 eyes (60 patients) were selected for this study, with no ocular diseases other than cataract (scheduled for cataract surgery by one surgeon). Patients were randomly enrolled to receive nepafenac or diclofenac in the perioperative period, and cataract surgery was performed using torsional microcoaxial phacoemulsification and aspiration with intraocular lens implantation via a transconjunctival single-plane sclerocorneal incision at the 12 o’clock position. We compared intra- and intergroup differences preoperatively and postoperatively in conjunctival and corneal fluorescein staining scores, tear film breakup times, Schirmer’s tests, the Dry Eye Related Quality of Life Scores, and tear meniscus areas using anterior segment optical coherence tomography. Results: The diclofenac group had significantly higher conjunctival and corneal fluorescein staining scores at 4 weeks postoperatively compared with the nepafenac group (P<0.001). Within the diclofenac group, significantly higher conjunctival and corneal fluorescein staining scores were noted at 4 weeks postoperatively than those seen preoperatively (P<0.001) and at 1 week postoperatively (P<0.001). No statistically significant differences were found in any other items. Conclusions: Nepafenac ophthalmic suspension 0.1% is considered safe for the corneal epithelium after cataract surgery. Keywords: nepafenac, diclofenac, cornea, tear film, ocular surface, cataract surgery
format article
author Kawahara A
Utsunomiya T
Kato Y
Takayanagi Y
author_facet Kawahara A
Utsunomiya T
Kato Y
Takayanagi Y
author_sort Kawahara A
title Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial
title_short Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial
title_full Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial
title_fullStr Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial
title_full_unstemmed Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial
title_sort comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/8f45375696624ce8ba137a571e893953
work_keys_str_mv AT kawaharaa comparisonofeffectofnepafenacanddiclofenacophthalmicsolutionsoncorneatearfilmandocularsurfaceaftercataractsurgerytheresultsofarandomizedtrial
AT utsunomiyat comparisonofeffectofnepafenacanddiclofenacophthalmicsolutionsoncorneatearfilmandocularsurfaceaftercataractsurgerytheresultsofarandomizedtrial
AT katoy comparisonofeffectofnepafenacanddiclofenacophthalmicsolutionsoncorneatearfilmandocularsurfaceaftercataractsurgerytheresultsofarandomizedtrial
AT takayanagiy comparisonofeffectofnepafenacanddiclofenacophthalmicsolutionsoncorneatearfilmandocularsurfaceaftercataractsurgerytheresultsofarandomizedtrial
_version_ 1718403331527802880